Cannon Global Investment Management’s Viridian Therapeutics VRDN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-12,600	Closed	-$233K	–	66
2022 Q1	$233K	Buy	+12,600	New	+$233K	0.17%	87